Insys CEO Resigns Amid Uncertain Future
Troubled fentanyl spray maker Insys Therapeutics said Monday that its CEO has agreed to resign from the company as it attempts to enter the cannabinoid business but faces a murky future....To view the full article, register now.
Already a subscriber? Click here to view full article